+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

High Throughput Screening Market Size, Share & Trends Analysis Report By Product And Services (Consumables), By Technology (Cell-based Assays), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998669

High Throughput Screening Market Growth & Trends

The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

High Throughput Screening Market Report Highlights

  • The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
  • Emerging 3D cell culture technology that provides better results in real-time is set to boost the market
  • North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
  • Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. High Throughput Screening (HTS) Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. High Throughput Screening (HTS) Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. High Throughput Screening (HTS) Market: Product and Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. High Throughput Screening (HTS) Market: Product and services Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Consumables
4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.1.1. Reagents & Assay Kits
4.3.1.1.1. Reagents & Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.1.2. Laboratory Equipment
4.3.1.2.1. Laboratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Instruments
4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.1. Liquid Handling Systems
4.4.1.1.1. Liquid Handling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.2. Detection Systems
4.4.1.2.1. Detection Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.1.3. Other Instruments
4.4.1.3.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Software
4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. High Throughput Screening (HTS) Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. High Throughput Screening (HTS) Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Cell-based Assays
5.3.1. Cell-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1. Fluorometric Imaging Plate Reader Assays
5.3.1.1.1. Fluorometric Imaging Plate Reader Assays Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1.2. Clinical Applications
5.3.1.1.2.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.1.3. In-vitro Studies
5.3.1.1.3.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.2. Reporter Based Assays
5.3.1.2.1. Clinical Applications
5.3.1.2.1.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.2.2. In-vitro Studies
5.3.1.2.2.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3. 3D - Cell Cultures
5.3.1.3.1. 3D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3.2. Scaffold-based Technology
5.3.1.3.2.1. Scaffold-based Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.3.3. Scaffold-free Technology
5.3.1.3.3.1. Scaffold-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.4. 2D - Cell Cultures
5.3.1.4.1. 2D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.5. Reporter-based Assays
5.3.1.5.1. Reporter-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.1.6. Perfusion Cell Culture
5.3.1.6.1. Perfusion Cell Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Lab-on-a-chip Technology (LOC)
5.4.1. Lab-on-a-chip Technology (LOC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Label-free Technology
5.5.1. Label-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Ultra High Throughput Screening
5.6.1. Ultra High Throughput Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. High Throughput Screening (HTS) Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. High Throughput Screening (HTS) Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Drug Discovery Programs
6.3.1. Drug Discovery Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Chemical Biology Programs
6.4.1. Chemical Biology Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Biochemical Screening
6.5.1. Biochemical Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Cell & Organ-based Screening
6.6.1. Cell & Organ-based Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. High Throughput Screening (HTS) Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. High Throughput Screening (HTS) Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Pharmaceutical & Biopharmaceutical Companies
7.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Contract Research Organizations (CROs)
7.5.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Others
7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. High Throughput Screening (HTS) Market: Regional Estimates & Trend Analysis
8.1. High Throughput Screening (HTS) Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
8.2.1. North America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. U.S. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Canada High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.4. Mexico
8.2.4.1. Mexico High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
8.3.1. Europe High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.2. U.K.
8.3.2.1. U.K. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Germany High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.4. France
8.3.4.1. France High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Italy High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Spain High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.7. Denmark
8.3.7.1. Denmark High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.8. Sweden
8.3.8.1. Sweden High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Norway High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.2. China
8.4.2.1. China High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.3. Japan
8.4.3.1. Japan High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.4. India
8.4.4.1. India High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. South Korea High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Australia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Thailand High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Brazil High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.3. Argentina
8.5.3.1. Argentina High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.3. UAE
8.6.3.1. UAE High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.4. South Africa
8.6.4.1. South Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Kuwait High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Agilent Technologies, Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Danaher Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. PerkinElmer Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Aurora Biomed Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Tecan Trading AG
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Promega Corporation
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Charles River Laboratories.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Creative Biolabs.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives

Companies Mentioned

  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Aurora Biomed Inc.
  • Tecan Trading AG
  • Promega Corporation
  • Charles River Laboratories.
  • Creative Biolabs.

Methodology

Loading
LOADING...

Table Information